|
平成28年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査担当
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
| O157VT2 |
0 |
0 |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
3 |
4 |
| O157VT1,2 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
0 |
1 |
5 |
5 |
10 |
15 |
| その他 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
2 |
1 |
2 |
0 |
4 |
3 |
7 |
5 |
| 累計 |
1 |
1 |
3 |
6 |
6 |
8 |
9 |
9 |
10 |
11 |
15 |
19 |
21 |
23 |
32 |
41 |
62 |
86 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
3 |
8 |
5 |
8 |
13 |
6 |
3 |
0 |
2 |
3 |
2 |
1 |
3 |
3 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
4 |
5 |
6 |
12 |
16 |
44 |
31 |
4 |
2 |
0 |
3 |
2 |
1 |
3 |
1 |
1 |
0 |
0 |
| その他 |
3 |
1 |
3 |
0 |
6 |
4 |
2 |
1 |
0 |
0 |
4 |
3 |
0 |
0 |
2 |
0 |
2 |
1 |
| 累計 |
96 |
110 |
124 |
144 |
179 |
234 |
270 |
275 |
279 |
282 |
291 |
297 |
301 |
307 |
310 |
311 |
313 |
314 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
| O157VT1,2 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
| その他 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| 累計 |
1 |
2 |
2 |
2 |
2 |
3 |
3 |
3 |
3 |
6 |
7 |
8 |
9 |
10 |
12 |
12 |
13 |
14 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
2 |
2 |
2 |
1 |
3 |
1 |
2 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
1 |
0 |
0 |
1 |
1 |
2 |
1 |
0 |
1 |
1 |
1 |
2 |
0 |
0 |
2 |
0 |
0 |
| 累計 |
16 |
19 |
21 |
22 |
26 |
28 |
33 |
38 |
39 |
40 |
41 |
43 |
46 |
46 |
46 |
48 |
48 |
48 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| 累計 |
0 |
1 |
1 |
2 |
2 |
3 |
4 |
4 |
4 |
5 |
5 |
6 |
6 |
7 |
7 |
7 |
8 |
10 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
1 |
1 |
2 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| O9 |
13 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
| その他 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
23 |
24 |
25 |
27 |
27 |
31 |
32 |
32 |
32 |
32 |
33 |
33 |
33 |
34 |
35 |
35 |
37 |
39 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
1 |
0 |
0 |
1 |
0 |
1 |
3 |
1 |
0 |
2 |
0 |
0 |
2 |
0 |
4 |
6 |
5 |
| O7 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
2 |
1 |
1 |
1 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
| その他 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
6 |
1 |
0 |
| 累計 |
0 |
3 |
4 |
4 |
5 |
6 |
7 |
10 |
13 |
14 |
16 |
16 |
18 |
25 |
26 |
37 |
45 |
50 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
5 |
2 |
1 |
1 |
2 |
1 |
2 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O7 |
0 |
2 |
0 |
0 |
1 |
1 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
1 |
2 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
51 |
58 |
61 |
64 |
67 |
70 |
76 |
79 |
80 |
81 |
81 |
81 |
81 |
81 |
82 |
82 |
84 |
84 |
|
